Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”

by Sarah Moniz | Feb 6, 2018

De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy

by Sarah Moniz | Jan 18, 2018

T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin

by Sarah Moniz | Dec 19, 2017

An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice

by Adam | Sep 21, 2017

Immunoinformatics tools were used to predict human leukocyte antigen (HLA) class II-restricted T cell epitopes within the envelope glycoproteins and nucleocapsid proteins of Ebola virus (EBOV) and Sudan virus (SUDV) and the structural proteins of Venezuelan equine...

Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein

by Adam | Oct 22, 2016

Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein Scios Inc, Brown University, Amgen Clinical Immunology (2007). [ISPRI prediction of immunogenicity]